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INTRODUCTION 
 
 Diabetes Mellitus is a group of metabolic disorders characterized 
by, a deficiency of insulin secretion and / or insulin effect, which 
causes hyperglycemia, disturbances of carbohydrate, fat and protein 
metabolism and a constellation of chronic complications. 
 
 Diabetes is and will remain a threat to global health. World wide 
diabetes probably affects 150 million people and its prevalence is 
predicted to double by 2015. 
 
 The incidence of diabetes is showing an alarming rise in 
developing countries, particularly in India. 60-80% of the diabetics in 
developed countries are obese. Whereas in India we find that clinical 
profile of diabetics is different. 
 
 Most of the patients attending our diabetic clinic are not obese 
as defined by existing parameters such as BMI. It is interesting to note 
that most patients fall in normal weight group and some even lean 
group. Obesity in type 2 diabetes is uncommon in Indian population 
compared to western population. 
 
 So, it is worth studying the clinical profile of lean type 2 diabetes, 
by comparing with normal and obese population with type 2 diabetes. 
  
REVIEW OF LITERATURE 
 
Diabetes Mellitus comprises a group of metabolic disorders that 
share the phenotype of hyperglycemia due to absolute or relative 
deficiency of insulin. Several distinct types of Diabetes Mellitus exist 
and are caused by a complex interaction of genetics, environmental 
factors and life style choices. Lack of insulin affects the metabolism of 
carbohydrates, protein and fat and causes a significant disturbance of 
water and electrolyte homeostasis. Though acute metabolic 
decompensation is fatal, long standing metabolic derangement is 
frequently associated with permanent and preventable functional and 
structural changes in the cells of the body, with those of the vascular 
system being particularly susceptible. These changes lead to the 
development of well defined clinical entities the so called complications 
of diabetes which characteristically affect the eye, kidney and the 
nervous system. 
 
Classification 
Although all forms of DM are characterised by hyperglycemia 
the pathogenic mechanisms by which hyperglycemia arises differ 
widely. Some forms of DM are characterised by an absolute insulin 
deficiency or a genetic defect leading to defective insulin reaction, 
  
whereas other forms share insulin resistance as their underlying 
etiology. 
 
The two broad categories are designated as Type 1 and Type 2 
Type lA Diabetes Mellitus results from autoimmune beta cell 
destruction, which usually leads to insulin deficiency. Type 1 B 
Diabetes Mellitus is also characterised by insulin deficiency as well as 
tendency to develop ketosis. But individuals with type 1 B Diabetes 
Mellitus lack immunologic markers indicative of an autoimmune 
destructive process of beta cells. 
 
Type 2 Diabetes Mellitus is a heterogeneous group of disorders 
usually characterised by variable degrees of insulin resistance, 
impaired insulin secretion and increased glucose production. 
 
Other types of Diabetes Mellitus: 
Other etiologies of Diabetes Mellitus include specific genetic 
defects in insulin secretion or action, metabolic abnormalities that 
impair insulin secretion, and a host of conditions that impair glucose 
tolerance. 
 
  
Maturity onset diabetes of the young (MODY) is a subtype of 
Diabetes Mellitus characterised by autosomal dominant inheritance, 
early onset of hyperglycemia and impairment in insulin secretion. 
Mutation is the insulin receptor cause a group of rare disorders 
characterised by severe insulin resistance. 
 
Diabetes Mellitus can result from pancreatic exocrine disease 
when the majority of pancreatic islets (>80%) are destroyed. 
Endocrinopathies such as Acromegaly and Cushing's disease, present 
with Diabetes Mellitus. Rarely viral infections such as rubella have 
been implicated in pancreatic islet cell destruction. 
 
Gestational diabetes mellitus: 
Insulin resistance related to the metabolic changes of late 
pregnancy increases insulin requirements and may lead to 
hyperglycemia or impaired glucose tolerance. 
 
Epidemiology: 
Diabetes remains as a threat to global health. World wide the 
prevalence of Diabetes is estimated to increase from 4% in 1995 to 
5.4% by the year 2025. India has the dubious distinction of having the 
largest number of diabetics in the world. 
  
The prevalence 'of Diabetes in India Study (PODIS) showed that 
type 2 Diabetes Mellitus was found in 7.06% of the population, which 
is expected to double by 2015. Diabetes Mellitus is the leading cause 
of end stage renal disease, non traumatic lower extremity amputation 
and adult blindness in U.S. The increasing prevalence of Diabetes 
Mellitus is largely attributed to increasing obesity and reduced activity 
levels. 
 
 The prevalence of Type 2 DM and its harbinger, IGT is highest 
in certain pacific islands, intermediate in countries such as India and 
United States, relatively less in Russia and China. 
 
 This variability is likely due to genetic, behavioral and 
environmental factors. 
 
Criteria for the Diagnosis of Diabetes Mellitus 
(National Diabetes Data Group and World Health Organisation) 
 Symptoms of Diabetes plus random blood glucose concentration 
> 11.1 mmol/L (200 mg/dl)a 
(or) 
 Fasting plasma glucose > 7.0 mmol/L (126 mg/dl)b 
(or) 
  
 Two hour plasma glucose > 11.1 mmol/L (200 mg/dl) during an 
oral glucose tolerance test c 
 
a) Random is defined as without regard to time since the last 
meal. 
b) Fasting is defined as no caloric intake for at least 8 hours. 
c) The test should be performed using a glucose load 
containing the equivalent of 75 gm anhydrons – glucose 
dissolved in water : not recommended for routine clinical 
use. 
Source : Modified from American Diabetes Association, 
2004 
 
PATHOGENESIS 
 
Type 1 Diabetes Mellitus: 
Type 1 A Diabetes Mellitus develops as a result of the 
synergetic effects of genetic environmental and immunologic factors 
that ultimately destroy the pancreatic beta cells.  
 
1. Genetic Factors :- 
Account for one third of the susceptibility to Type 1 Diabetes, the 
inheritance of which is polygenic. Over 20 different regions of the 
  
human genome show some linkage with type 1 diabetes, but most 
interest has focused on the human leucocyte antigen (HLA), on the 
short arm of chromosome 6. This focus is designated IDDM 1. The 
HLA haplotypes DR3 and / or DR4 alleles are associated with 
increased susceptibility to type 1 diabetes. 
 
2. Environmental factors:- 
Although genetic susceptibility to be a prerequisite for the 
development of type 1 diabetes, the concordance rate between 
monozygotic twins is less than 40%. Environmental factors have an 
important role in promoting clinical expression of the disease. 
 
"The hygiene hypothesis" :- Lack of exposure to pathogenic 
organisms in early childhood limits maturation of the immune system 
and increases susceptibility to autoimmune disease. 
 
3. Viruses :- 
Several viruses have been implicated, including mumps, 
Coxsackie B4, retroviruses, rubella (in utero) Cytomegalovirus and 
Epstein – Barr virus. 
 
 
  
4. Diet :- 
Bovine serum albumin (BSA), a major constituent of cow's milk, 
has been implicated in triggering type 1 diabetes. It has been shown 
that children who are given cow's milk early in infancy are more likely 
to develop type 1 diabetes than who are breast fed. 
 
5. Stress :- 
Stress may progress the development of type 1 diabetes, by 
increasing counter regulatory hormones and possibly by modulating 
immune activity. 
 
6. Immunological factors 
Type 2 diabetes is a slow T cell mediated autoimmune disease. 
Family studies have produced evidence that destruction of the insulin 
– secreting cells in the pancreatic islets takes place over many years. 
 
  
Pathogenesis of Type 1 Diabetes 
Normal islet cells 
 
? Viral infection in pancreatic  
beta cells 
 
Secretion of interferon α –  
by pancreatic beta cells 
 
Hyper expression of class 1  
MHC Antigen within islets 
 
Insulitis 
 
Selective destruction of beta cells  
(glucagon secretion preserved) 
 
Insulin deficient islet. 
 
Type 2 Diabetes Mellitus 
 Type 2 Diabetes mellitus commonly occurs in subjects who are 
obese and insulin resistant, but these two factors alone are insufficient 
to cause diabetes unless accompanied by impaired beta cell function. 
 
  
1. Genetics 
 Genetic factors are more important in the Aetiology of type 2 DM 
than type 1 diabetes, as shown by studies in monozygotic twins where 
concordance rates of type 2 diabetes approach 100%. 
 
2. Environmental Factors 
 The majority of cases of type 2 diabetes are multifactorial in 
nature, with interaction of environmental and genetic factors. 
a) Life style :- over eating, especially when combined with 
obesity and underactivity. 
b) Malnutrition in utero :- It is proposed that, (but not yet 
proven), malnutrition in utero may programme – beta cell 
development and metabolic functions at a critical period, so 
predisposing to type 2 diabetes later in life. 
c) Age : Age is an important risk factor for type 2 diabetes. 
Type 2 Diabetes principally a disease of the middle aged and 
elderly, affecting 10% of the population over the age of 65. 
d) Pregnancy : During normal pregnancy, insulin sensitivity is 
reduced through the action of placental hormones and this 
affects glucose tolerance. 
 
  
Pathogenesis of Type 2 Diabetes Mellitus 
i) Insulin resistance 
ii) Pancreatic Beta cell failure 
 
1. Insulin Resistance 
 Increased hepatic production of glucose and resistance to the 
action of insulin in muscle are invariable in both obese and non obese 
patients with type 2 diabetes. Insulin resistance may be due to  
a) an abnormal insulin molecule 
b) an excessive amount of circulating antagonists or 
c) Target tissue defects 
The last is the most common cause of insulin resistance in type 
2 diabetes. 
 
2. Pancreatic Beta Cell Failure 
 In type 2 DM, there is only moderate reduction in the total mass 
of pancreatic islet tissue which is consistent with a measurable fall in 
plasma insulin concentration. Some pathological changes are typical 
of type 2 diabetes, most constituent of which is deposition of amyloid. 
 
 While beta cell numbers are reduced by 20-30% in type 2 
diabetes, alpha cell mass is unchanged and glucagons secretion is 
increased, which may constituents to the hyperglycemic. 
  
 Some people with type 2 diabetes, most of whom are not 
overweight, have advanced pancreatic beta cell failure at the time 
of presentation and require early treatment with insulin. 
 
Complications of DM : 
Acute Complications: 
Diabetic ketoacidosis (DKA) and Non ketotic hyperosmolar 
coma (HONK) are acute complications of diabetes. DKA is seen 
primarily in individuals with type 1 Diabetes Mellitus, and HONK is 
seen in individuals with type 2 Diabetes Mellitus. Both disorders are 
associated with absolute or relative insulin deficiency, volume 
depletion and altered mental status. Both are associated with 
potentially serious complications if not promptly diagnosed and 
treated. 
 
Chronic complications: 
Chronic complication of DM affect many organ systems and are 
responsible for majority of morbidity and mortality. 
 
Chronic complications of Diabetes Mellitus: 
Microvascular: 
Eye disease: Retinopathy  
  
Macular oedema  
Cataract  
Glaucoma 
  
Neuropathy:  Sensory and Motor 
Autonomic 
 
Nephropathy: 
 
Macrovascular : 
 Coronary artery disease 
 Peripheral vascular disease 
 Cerebrovascular disease 
 
Others: 
 Gastrointestinal 
 Genito urinary 
 Dermatologic 
 
The risk of complications of both type 1 and type 2 increase as a 
function of the duration of hyperglycemia. They usually become 
apparent in the second decade of hyperglycemia. 
  
Mechanism of complications: 
Three major theories have been proposed to explain the 
emergence of complications. 
1. Increased intracellular glucose leads to the formation of 
advanced glycosylation end products (AGE's) via non 
enzymatic glycosylation of cellular proteins, AGE's have 
been shown to cross link. Proteins, accelerate 
atherosclerosis, promote glomerular dysfunction, reduce 
nitric oxide synthesis, induce endothelial dysfunction and 
alter the extracellular matrix composition and structure. 
2. Hyperglycemia increases glucose metabolism via the 
sorbitol pathway. Increased intracellular glucose is 
converted to sorbitol by the enzyme aldose reductase. 
Increased sorbitol concentrations affect several aspects of 
cellular physiology and may lead to cellular dysfunction. 
3. Hyperglycemia increases the formation of diacylglycerol 
leading to activation of certain isoforms of protein kinase 
C, which in turn, affect a variety of cellular events that lead 
to Diabetes Mellitus related complications. 
 
Finally oxidative stress and free radical generation may also 
promote the development of complication. 
  
Diabetic Retinopathy: 
Diabetic retinopathy is the most common cause of blindness in 
adults. 
  
Hyperglycemia increases retinal blood flow and metabolism and 
has direct effects on retinal endothelial cells and pericytes, loss of 
which impairs vascular auto regulation. The resulting uncontrolled 
blood flow increases production of vasoactive substances and 
endothelial cell proliferation resulting in capillary closure. This causes 
chronic retinal hypoxia and stimulates production of growth factors, 
including vascular endothelial growth factor (VEGF) to stimulate 
endothelial cell growth (causing new vessel formation) and increased 
vascular permeability (causing exudative damage). 
 
Diabetic Nephropathy: 
Diabetic Nephropathy is the leading cause of end stage renal 
disease (ESRD) in many countries. 
 
Mechanism of chronic hyperglycemia to ESRD involve 
1. interaction of soluble factors ( AT II, AGEs, Endothelin) 
2. hemodynamic alterations in renal microcirculation. 
3. structural charges in glomerulus. 
  
Diabetic neuropathy 
"A descriptive term meaning a demonstrable disorder, either 
clinically evident or subclinical, that occurs in the setting of diabetes 
mellitus without other causes for peripheral neuropathy. The 
neuropathic disorder includes manifestations in the somatic and/or 
autonomic parts of the peripheral nervous system. 
 
Aetiopathogenesis of Diabetic Neuropathy 
Hypotheses concerning the multiple etiologies of diabetic 
neuropathy include a metabolic insult to nerve fibers, neurovascular 
insufficiency, autoimmune damage, and neurohormonal growth factor 
deficiency. Several different factors have been implicated in this 
pathogenic process. Hyperglycemic activation of the polyol pathway 
leading to accumulation of sorbitol and potential changes in the 
NAD:NADH ratio may cause direct neuronal damage and/or 
decreased nerve blood flow.(Greene et al,1983) Activation of protein 
kinase C induces vasoconstriction and reduces neuronal blood 
flow(Veves et al,200 1) Increased oxidative stress, with increased free 
radical production, causes" vascular endothelium damage and reduces 
nitric oxide bioavailability (Cameron et ai, 1997)Alternately, excess 
nitric oxide production may result in formation of peroxynitrite and 
damage endothelium and neurons, a process referred to as nitrosative 
  
stress. In a subpopulation of individuals with neuropathy, immune 
mechanisms may also be involved. Reduction in neurotrophic growth 
factors, deficiency of essential fatty acids, and formation of advanced 
glycosylation end products (localized in endoneurial blood vessels 
(Brownlee ,1992) also result in reduced endoneurial blood flow and 
nerve hypoxia with altered nerve function. The result of this 
multifactorial process may be activation of polyADP ribosylation 
depletion of A TP, resulting in cell necrosis and activation of genes 
involved in neuronal damage". 
 
Diabetic autonomic neuropathy 
A subtype of the peripheral polyneuropathies that accompany 
diabetes, Diabetic autonomic neuropathy can involve the entire 
autonomic nervous system (ANS). ANS vasomotor, visceromotor, and 
sensory fibers innervate every organ. Diabetic autonomic neuropathy 
may be either clinically evident or subclinical. It is manifested by 
dysfunction of one or more organ systems (e.g., cardiovascular, 
gastrointestinal [GI], genitourinary, sudomotor, or ocular). Indeed, 
because the vagus nerve (the longest of the ANS nerves) accounts for 
roughly 75% of all parasympathetic activity), and Diabetic autonomic 
neuropathy manifests first in longer nerves. Symptoms suggestive of 
autonomic dysfunction may be common they may frequently be due to 
other causes rather than to true autonomic neuropathy. Subclinical 
  
autonomic dysfunction can, however, occur within a year of diagnosis 
in type 2 diabetes patients (Pfeifer et al,1984).Because of its 
association with a variety of adverse outcomes including 
cardiovascular deaths, cardiovascular autonomic neuropathy (CAN) is 
the most clinically important and well-studied form of Diabetic 
autonomic neuropathy. 
 
Macrovascular Complications 
 
1. Cardiovascular Morbidity and Mortality 
 Framingham Heart study revealed a marked increase in 
congestive heart failure, coronary artery disease, myocardial infarction 
(MI), Peripheral arterial disease and sudden death (risk increase from 
one to five fold) in DM. 
 
 American Heart Association recently designated Diabetes 
mellitus as a major risk factor for cardiovascular disease (same 
category as smoking, hypertension and hyperlipedemia). 
 
 The absence of chest pain (silent ischemic) is common in 
individuals with diabetes and a thorough cardiac evaluation is 
indicated. Coronary artery disease is more likely to involve multiple 
vessels in individuals with diabetes mellitus. 
 
  
2. Hypertension 
 Hypertension in diabetes mellitus can accelerate other 
complications of DM, particularly cardiovascular disease, and 
nephropathy. Blood pressure goal in individual with diabetes is < 130 / 
80 mm Hg. Hypertension is often difficult to control with a single agent 
especially in type 2 diabetes, multiple antihypertensive agents are 
usually required. 
 
3. Dyslipidemia 
 Individuals with diabetes may have several forms of 
dyslipidemia. Because of additive – cardiovascular risk of 
hyperglycemia and hyperlipidemia, lipid abnormalities should be 
aggressively detected and treated. Most common pattern of 
dyslipidemia is hypertriglyceridemia and reduced HDL cholesterol 
levels. 
 
 Target lipid values in diabetic individual without cardiovascular 
disease should be, 
o LDL < 100 mg/dl  
o In men, HDL (>40 mg/dl) 
In women, HDL (>50 mg/dl) 
o Triglycerides < 150 ml/dl 
 
  
4) Lower extremity complications 
 Diabetes is the leading cause of non traumatic lower extremity 
amputation in U.S. Foot ulcers and infections are also a major source 
of morbidity in individuals with DM. 
 
5) Infections 
 Individuals with DM have a greater frequency and severity of 
infection. The reasons for this include incompletely defined 
abnormalities in cell mediated immunity and phagotypic function 
associated with hyperglycemia, as well as diminished vascularisation. 
 
 Cardiac and other fungal infections, emphysematons infections 
of the gall bladder and urinary tract, pneumonia and skin and soft 
tissue infections are all more common in diabetic population. However 
gram negative organisms, in tuberculosis and S. Aureus also more 
frequent pathogens. 
 
Diabetic skin complications 
 Some of them are 
1. Diabetic dermopathy – begins as a erythematous area and 
evolves into an area of circular hyper pigmentation. 
2. Necrobiosis Lipoidica – Diabeticorum – usually begins in 
the pretibial region as an erythematous plaque or papules 
  
that gradually enlarge, darken and develop irregular – 
margins with atrophic centers and central ulceration. 
3. Acanthosis nigricans – Hyperpigmented velvety plaques 
seen on the neck, axilla, or extensor surfaces, is sometimes 
a feature of severe insulin resistance. 
4. Granuloma Annulare – erythematous plaques on the 
extremities or trunk. 
5. Scleredema – Area of skin thickening on the back or neck at 
the site of previous superficial infections. 
6. Lipoatrophy and Lipohypertrophy 
7. Xerosis and pruritus are common. 
 
Clinical profile of lean type 2 diabetes  
Articles review 
1. Clinical profile of lean type 2 diabetes – study conducted at 
Madras Diabetes Research Foundation, India with 347 lean, 
6274 normal and 3252 obese type 2 diabetes patients in 2002 
observed. 
a. 60% are non obese and lean type 2 DM constituted 3.5%. 
b. Increased prevalence of retinopathy, nephropathy and 
neuropathy in lean type 2 DM patients. 
 
  
2. Clinical profile of type 2 diabetes mellitus and body mass index – 
is there any correlation?. Study conducted with 500 patients at 
Manipal, Kasthuriba Medical College by Prabhu Mukhyaprana 
M, in 2004, observed, 
a. Majority (65%) belonged to normal weight diabetes group, 
and 7.1% were lean diabetics. 
b. Most of the lean diabetics were males (65%) with less 
positive family history. 
c. There was 2 linear increase in number of patients having 
abnormal WHR with increase in BMI. 
d. Microvascular complications were found in similar, 
proportion in all groups. 
e. Lean diabetics are less prone to develop macro vascular 
complications like HT and IHD. 
f. Lean diabetics have more severe hyperglycemia and poor 
metabolic control. 
g. Analysis of lipid profile showed, all the parameters were 
lower in lean diabetics compared to all other groups i.e. 
normal and obese patients. 
 
3. Clinical profile of lean body weight type 2 DM patients in 
comparison with obese and non obese type 2 diabetes patients. 
  
Study conducted at Jamnagar, M.P. Shah Medical 
College by Gohel DR, Deszi VK, in 2002-2003 observed very 
similar results as previous studies. In addition, 
 
i) Increased incidence of higher fasting plasma 
glucose (239+42.5) in lean diabetics. 
ii) Peripheral neuropathy (52%) and infections 
(42%) were the commonest presenting clinical 
features in lean patients. 
 
4. Increased prevalence of Retinopathy, nephropathy and 
neuropathy in lean diabetics; Mohan et al . 
 
5. Studies by Banerji et al and Dass et al had showed slight 
increase in Triglycerides (TGL) and HDL in lean diabetes. 
 
6. Japanese study by Ikeda et al showed no major differences in 
lipid profile in lean diabetics irrespective of glycemic status. 
 
 
 
 
  
 
 
 
 
AIM OF THE STUDY 
  
AIM OF THE STUDY 
 
1. To Study and compare the clinical profile of Lean Body 
weight Type 2 Diabetes Mellitus patients – in comparison 
with obese and Normal weight Type 2 DM patients, by age, 
sex, family history and Anthropometry. 
 
2. To compare the "presenting complications" of the lean with 
normal weight and obese type 2 Diabetes patients. 
 
3. To compare the Biochemistry profile of the lean type 2 
Diabetes with normal and obese type 2 DM, that is Blood 
Glucose, Urea, Serum Creatinine and Lipid profile. 
 
  
 
 
 
 
 
MATERIALS AND 
METHODS 
  
MATERIALS AND METHODS 
 
Materials 
 The study included hundred patients with Type 2 Diabetes 
mellitus attending the out patients in Departments of Medicine and 
Diabetology, Government Rajaji Hospital between July 2005 and June 
2006, one year period. 
 
 Those hundred patients divided into three groups based on 
Body Mass Index (BMI). 
 
 Group A: BMI < 18.5 Kg/m2 (Lean Body Weight Type 2 
DM) 
 
 Group B: BMI, between 18.5 and 25 Kg/m2 (Normal 
Weight Type 2 DM). 
  
 Group C: BMI > 25 Kg/m2 (Obese Type 2 DM) 
 
 A careful detailed history were taken from each person, i.e. Age 
of onset, duration, any positive family history, dietary pattern, 
presenting complaints – at the time of diagnosis etc. 
  
 Detailed examination were done for all the hundred patients to 
find out various complications, if any. 
 
 Biochemically, Blood glucose (Both fasting and post prandial), 
Blood urea, Serum Creatinine, Lipid profile were analysed in all the 
three groups. 
 
Selection of cases 
 Cases included in the study were selected as per the records 
available with them. 
 
 Duration of disease, Body Mass Index, Waist Hip Ratio, current 
Blood Glucose, Urea, Serum Creatinine and Lipid profile were taken 
into consideration. 
 
Exclusion Criteria for cases 
1. Presence of pulmonary tuberculosis history. 
2. Presence of other chronic illnesses that could affect Body 
weight like chronic liver and chronic kidney disease. 
3. Type 2 Diabetes patients with Age of onset less than 30 
years. 
  
4. History wise, particularly in lean patients those who were 
normal or obese at the time of presentation, now lost the 
body weight significantly after type 2 Diabetes mellitus 
detection. 
5. Patient with history of Cancer, Cachexia and HIV. 
 
Selection of Controls 
 Control cases were normal weight as well as obese patients with 
Type 2 Diabetes Mellitus. 
 
Methods 
1. Height (in meter), Weight (in kg) measured in all patients. 
BMI (Body Mass Index) calculated based on the formula, 
BMI  = Weight (kg) 
  (Kg/m2)  Height (in m2) 
           (Quetelet) 
 
2. Waist hip Ratio (W/H Ratio) 'Waist Circumference' measured 
at midpoint between the costal margin and anterior superior 
iliac spine. 
 
Hip Measurement taken as maximum diameter at the greater 
trochanter. 
 
  
Waist / Hip Ratio (WHR) was calculated in each case. 
 
Waist Hip ratio was considered abnormal if > 0.95 for males 
and > 0.8 for females. 
 
3. Skin Fold Thickness (SFT) 
Skin Fold Thickness was measured at standard sits such as 
the Biceps, Triceps, infrascapular, and supra iliac region 
using a Harpenden Calliper or similar device. 
 
The Calliper is designed so that the jaws of the device remain 
parallel and constant pressure is exerted between them or 
different skin fold thicknesses. 
 
Triceps skinfold, midway between abdomen and olecranum, 
is used in our study. 
 
Patients were clinically screened for microvascular and 
macrovascular complications. 
 Patients were considered as hypertensive if blood 
pressure was > 130/85 mm Hg. 
 
  
 Patients were considered as having ischemic heart 
disease based on ischemic changes in the ECG or by 
demonstrating hypokinetic or akinetic segment in the 
echocardiogram for selected patients. 
 
 Ophtholmoscopy was done to diagnose diabetic 
retinopathy. 
 
 Neuropathy was diagnosed, based on subjective 
symptoms or objective evidence in the form of loss of 
ankle jerk or glove and stocking type of anaesthesia. 
 
 Nephropathy was diagnosed based on blood urea and 
serum creatinine values. 
 
 Fasting, post prandial glucose, fasting lipid profile and 
other relevant investigations were done in each case. 
 
Definitions and Cut Off values for the study 
1. Body Mass Index (BMI) 
18.5-24 (kg/m2) – taken as normal value 
< 18.5 (kg/m2) – lean body weight 
> 25 (kg/m2) – obese body weight 
  
2. Waist Hip Ratio 
WHR - > 0.8 – is taken as abnormal value in female. 
 > 0.95 in male as abnormal value. 
 
3. SFT (Skin Fold Thickness) 
(in mm) 
> 12.5 – abnormal in male. 
> 16.5 – abnormal in females. 
 
4. Fasting 'Hyper glycemia' – (FBS) 
'Fasting' means 8 hours fasting overnight. 
 
Fasting Hyperglycemia means if Blood glucose value > 
126 mg% 
 
5. Post prandial Hyperglycemia (PPBS) 
Post prandial measures at 2 hours after the meals. 
 
Post prandial hyperglycemia means if value > 200 mg% 
 
6. Lipid Profile 
Lipid profile taken after 8 hours overnight fasting. 
 
  
Normal Value Range 
Free cholesterol 150-200 mg 
Triglycerides 75-150 mg% 
HDL 30-60 mg% 
VLDL 20-40 mg% 
LDL 80-150 mg% 
 
Others 
 Blood is drawn from each patient under recommended ideal 
conditions to determine the fasting and post prandial Blood sugar, 
urea, serum creatinine and Lipid profile. 
 
Ethical Committee Approval 
 The present study was approved by the ethical committee. 
 
Statistical Analysis 
 Statistical Analysis of data was done by using the software – 
Epidemiological Information Package (EPI 6) developed by World 
Health Organisation. 
 Frequencies, Percentages, Range, Median, Mean, S.D. and 'p' 
values were calculated using this package. 
  
 
 
 
 
RESULTS AND 
OBSERVATIONS 
  
RESULTS AND OBSERVATIONS 
 
Table 1 
Characteristics of the study population 
 
Characteristics Range Median Mean S.D. 
Age 30-90 50 49.8 12.3 
BMI 16-31 22.25 22.89 4.25 
W/H Ratio 
a) Males 
b) Females 
c) Total 
 
0.78-1.04 
0.74-1.02 
0.74-1.04 
 
0.9 
0.86 
0.9 
 
0.91 
0.87 
0.9 
 
0.05 
0.07 
0.06 
SF Thickness 
a) Males 
b) Females 
c) Total 
 
8-18 
8-22 
8-22 
 
12 
11.5 
12 
 
12.2 
12.5 
12.3 
 
2.4 
3.7 
3.0 
Fasting Blood Sugar 60-445 215 221.3 86.4 
P.P. Blood Sugar 130-642 280 306.3 111.9 
Free cholesterol  110-381 204 213.9 60.0 
TGL 95-327 160 158.2 34 
LDL 36-317 104 121.2 60.4 
HDL 25-45 40 37.3 5.0 
VLDL 19-65 32 32.1 7.9 
Systolic BP 100-220 130 132.4 23.1 
Diastolic BP 60-120 80 85.3 11.8 
 
 
  
Table 2 
 
Characteristics No. % 
Sex 
a) Males 
b) Females 
 
56 
44 
 
56 
44 
Family History 
a) Yes 
b) No 
 
24 
76 
 
24 
76 
Complications 
a) Cardiac 
Yes 
No 
b) Renal 
Yes 
No 
c) Neuro 
Yes 
No 
d) Retinopathy 
Yes 
No 
e) Infections 
Yes 
No 
f) HT 
Yes 
No 
 
 
16 
82 
 
50 
50 
 
44 
56 
 
38 
62 
 
36 
64 
 
30 
70 
 
 
18 
82 
 
50 
50 
 
44 
56 
 
38 
62 
 
36 
64 
 
30 
70 
BMI 
a) Lean 
b) Normal 
c) Obese 
 
18 
52 
30 
 
18 
52 
30 
  
RELATIONSHIP BETWEEN BODY MASS INDEX AND OTHER 
PARAMETERS 
 
Table 3 
Age and BMI 
 
BMI 
Lean Normal Obese 
Age Group 
No. % No. % No. % 
< 40 4 22.2 20 38.5 6 20 
41-50 4 22.2 20 23.1 8 26.7 
51-60 6 33.4 12 23.1 16 53.3 
>60 4 22.2 8 15.3 - - 
Total 18 100 52 100 30 100 
Mean 
S.D. 
53.2 
17.9 
48.1 
11.7 
50.7 
9.6 
P 0.4695 
 
 There is no statistically significant relationship between age and 
BMI. 
 
  
Table 4 
Sex and BMI 
 
BMI 
Lean Normal Obese 
Sex 
No. % No. % No. % 
Male (56) 8 14.3 38 67.9 10 17.9 
Female (44) 10 22.7 14 31.8 20 45.5 
P 0.0364 
 
 There is statistically significant relationship between sex and 
BMI. 
Table 5 
Family History and BMI 
 
BMI 
Lean Normal Obese 
Family History 
No. % No. % No. % 
Yes (42) 2 4.8 26 61.9 14 33.3 
No(58) 16 27.6 26 44.8 16 27.6 
P 0.0399 (Significant) 
 
Percentage of lean cases is low in persons with family history. 
  
Table 6 
Waist Hip Ratio and BMI 
 
BMI 
Lean Normal Obese 
W/H Ratio 
No. % No. % No. % 
Normal (54) 12 22.2 38 70.4 4 7.4 
Abnormal (46) 6 13 14 30.4 26 56.5 
Mean W/H 
Ratio 
S.D. 
0.85 
 
0.06 
0.9 
 
0.06 
0.92 
 
0.06 
P 0.0379 
 
 Waist Hip Ratio has a statistically significant relationship with 
BMI. 
 
  
Table 7 
S.F Thickness and BMI 
 
BMI 
Lean Normal Obese 
S.F Thickness 
No. % No. % No. % 
Normal (78) 16 20.5 40 51.3 22 28.2 
Abnormal (22) 2 9.1 12 54.5 8 36.4 
Mean SF 
S.D. 
10 
2.06 
12.25 
2.74 
13.9 
3.11 
P 0.0016 
 
Statistically significant relationship exists between SF Thickness 
and BMI. As BMI increases, mean SF Thickness also increases. 
 
  
Table 8 
Fasting Blood Sugar and BMI 
 
BMI 
Lean Normal Obese 
Fasting Blood 
Sugar 
No. % No. % No. % 
Normal (14) 2 14.2 6 42.9 6 42.9 
Abnormal(86) 16 18.6 46 53.5 24 27.9 
Mean  
S.D. 
270.6 
105.9 
202.3 
76.6 
172.6 
55.6 
P 0.0425 (Significant) 
 
Lean persons have higher fasting blood sugar levels than obese 
persons. The difference is also statistically significant. 
 
  
Table 9 
Post Prandial Blood Sugar and BMI 
 
BMI 
Lean Normal Obese 
Post prandial 
Blood Sugar 
No. % No. % No. % 
Normal (8) 2 25 4 50 2 25 
Abnormal (92) 16 17.4 48 52.2 28 30.4 
Mean  
S.D. 
305.6 
121.7 
317.5 
130.4 
287.5 
66.7 
p 0.9664 
 
No significant relationship 
  
Table 10 
Free Cholesterol and BMI 
 
BMI 
Lean Normal Obese 
Free 
Cholesterol 
No. % No. % No. % 
Normal (48) 14 29.2 24 50 10 20.8 
Abnormal (52) 4 7.7 28 53.8 20 38.5 
Mean  
S.D. 
180.1 
53.3 
215.9 
61.9 
230.7 
55.7 
p 0.0765 
 
 As BMI increases, free cholesterol levels also increase. But the 
difference is not statistically significant. 
 
  
Table 11 
TGL and BMI 
 
BMI 
Lean Normal Obese 
TGL 
No. % No. % No. % 
Normal (40) 12 30 20 50 8 20 
Abnormal (60) 6 10 32 53.3 22 36.7 
Mean  
S.D. 
145.4 
20.2 
158.8 
41.3 
164.6 
24.9 
p 0.117 
 
No significant relationship. 
 
Table 12 
LDL and BMI 
 
BMI 
Lean Normal Obese 
LDL 
No. % No. % No. % 
Normal (76) 14 18.4 42 55.3 20 26.3 
Abnormal (24) 4 16.7 10 41.7 10 41.7 
Mean  
S.D. 
101.4 
43.5 
116.6 
62.2 
140.9 
63.9 
p 0.0849 
 
Not significant. 
 
  
Table 13 
HDL and BMI 
 
BMI 
Lean Normal Obese 
HDL 
No. % No. % No. % 
Normal (92) 18 19.6 50 54.3 24 26.1 
Abnormal (8) - - 2 25 6 75 
Mean  
S.D. 
41 
2 
38.2 
3.6 
33.7 
6.2 
p 0.0037 
 
 As BMI increases, HDL levels decrease. The relationship is 
statistically significant. 
Table 14 
VLDL and BMI 
 
BMI 
Lean Normal Obese 
VLDL 
No. % No. % No. % 
Normal (94) 18 19.1 50 53.2 26 27.7 
Abnormal (6) - - 2 33.3 4 66.7 
Mean  
S.D. 
29 
3.94 
31.65 
8.2 
34.87 
8.53 
p 0.0618 
 
Not significant. 
 
  
Table 15 
Complications and BMI 
Cardiac, Renal, HT Incidence and BMI 
 
Complications 
Cardiac Renal H.T. 
Present Absent Present Absent Present Absent 
BMI 
No. % No. % No. % No. % No. % No. % 
Lean (18) - - 18 100 10 55.6 8 44.4 4 22.2 14 77.8
Normal 
(52) 
12 23.1 40 76.9 26 50 26 50 12 23.1 40 76.9
Obese 
(30) 
6 20 24 80 14 46.7 16 53.3 14 46.7 16 53.3
P 0.5491 (Not significant) 0.76 (Not significant) 0.0906 (Not significant) 
 
  
B. Neuropathy, Retinopathy and Infections incidence and BMI 
 
Complications 
Neuropathy Retinopathy Infections 
Present Absent Present Absent Present Absent 
BMI 
No. % No. % No. % No. % No. % No. % 
Lean 
(18) 
14 77.8 4 22.2 12 66.7 6 33.3 12 66.7 6 33.3
Normal 
(52) 
24 46.2 28 53.8 14 26.9 38 73.1 12 23.1 40 76.9
Obese 
(30) 
8 26.7 22 73.3 10 33.3 20 66.7 10 33.3 20 66.7
P 0.0399 (Significant) 0.0436 (Significant) 0.0314 (Significant) 
 
 
Incidence of neuropathy, Retinopathy and Infection is more in 
lean patients (77.8%, 66.7% and 66.7% respectively) than in the 
normal and obese patients. This relationship is statistically significant. 
 
  
 
 
 
 
 
DISCUSSION AND 
ANALYSIS OF RESULTS 
  
DISCUSSION AND ANALYSIS OF RESULTS 
 
"Diabetes Mellitus" is an age old affliction of man and is the most 
common metabolic disorder all over the world. The incidence of 
Diabetes showing alarming rise in developing countries, particularly in 
India. 
 
Most of the diabetics in developed countries are obese. 
However in India we have a significant number of diabetics who are 
either normal weight or even under weight. 
 
Eventhough obesity is considered as part of syndrome X in 
pathogenesis of type 2 diabetes, in our study, out of 100 patients only 
30 patients were obese. 
 
Our study included hundred patients. Among 100 patients, 56 
are males and 44 are females. In our study majority of patients, that is 
52 patients (52%) belong to normal weight, 30 patients (30%) belong 
to obese and 18 patients (18%) belong to lean body weight. 
 
 
 
  
1. Age 
 In our study, we found there is no particular age group for lean 
diabetics. But 33.4% of lean diabetics belong to 51-60 years of age, 
38.5% of normal weight patients between 30 and 40 years, and 53.3% 
of obese patients belong to 51-60 years of age group. 
 
2. Sex 
 There is statistically significant relationship exist in our study 
between sex and BMI. Slightly higher incidence of female in lean body 
weight (M : F Ratio = 0.8 : 1). In obese M : F Ratio is 1 : 2 and in 
normal body weight it is male preponderance (67.9%). 
 
3. Family History 
 Family history of diabetes is present only in 4.8% of lean 
diabetics, in comparison it is 61.9% in normal and 33.3% in obese 
diabetics. So there is  less incidence of family history present among 
lean diabetics. 
 
4. Waist Hip Ratio and BMI 
 There is a linear increase in number of patients having abnormal 
Waist Hip ratio with increase in BMI. 
 
  
 Among 100 patients studied, 46 patients having abnormal Waist 
Hip ratio. Among that it is 13% in lean, 31% in normal and 56% in 
obese type 2 diabetes having abnormal value. 
 
 Eventhough 18% (18) of diabetics patients are lean based on 
BMI, 6 among them having abnormal Waist hip ratio. So, Waist hip 
ratio is a better indicator than BMI for assessment of obesity . 
 
 Skin fold thickness also increases as the BMI increases. 
 
5. Complications 
Microvascular complications  
 Among the microvascular complications neuropathy (77.8%), 
Retinopathy (66.7%) are common in lean diabetics in our study 
which are statistically significant. Only 44.4% of lean diabetics had 
nephropathy, which is not statistically significant. 
 
 In normal weight group, incidence of neuropathy, retinopathy 
and nephropathy are 46.2%, 26.9% and 50% respectively. 
 
 In obese patients, incidence of neuropathy, retinopathy and 
nephropathy are 26.7%, 33.3% and 46.7%. 
  
Macrovascular Complications 
Lean diabetics are less prone to develop macrovascular 
complications – like hypertension and Ischemic Heart Disease. 
 
Incidence of hypertension is 22.2% in lean patients as compared 
to 23.1% in normal and 46.7% in obese diabetics, like wise Ischemic 
Heart Disease incidence in our study is 0% in lean diabetics as 
compared to 23.1% in normal and 20% in obese diabetics. 
 
Infections 
 In our study, 66.7% of lean patients with type 2 diabetes 
presented with infections as compare to 23.1% in normal and 33.1% in 
obese patients. Values are statistically significant p value = 0.0314. 
Majority of the lean diabetics in our study group presented with 
infections.  
 
Glycemic Control 
 Lean diabetics have more severe hyperglycemia with poor 
metabolic control. Lean persons have higher fasting blood sugar 
(270+105.9) levels than obese and normal weight type 2 diabetes 
patients. Similarly post prandial – value also high in lean type 2 DM 
patients. This has been explained by probable low beta cell reserve 
  
among lean diabetics. So, Lean diabetics are insulinopenic and 
highly insulin sensitive. 
 
Lipid Profile  
Regarding lipid profile of lean type 2 diabetes patients, all the 
parameters are lower in lean diabetics compared to all other groups. 
Moreover, lean diabetics have slightly higher HDL value (41.0+2.0) as 
compare to normal (38+4) and obese (33+6) diabetics, which is 
statistically significant. 
 
Also free cholesterol value in lean diabetics are (180 + 53) as 
compared to (215.9 + 61.9) and (230.7 + 55.7) in obese patients. 
 
Triglycerides value in lean diabetics (145 + 20) as compared to 
(158.8 + 41.3) in normal and (164.6 + 24.9) in obese diabetics.  
 
So, lean diabetics have favorable lipid profile as compared to 
normal and obese diabetics.  
 
 Our study has limitations, as it was hospital based in the 
tertiary – care setting. Incidence of complications might be higher 
compared to general population or primary case setting. We did not do 
  
insulin level assay, C peptide levels and GAD Antibodies in our lean 
diabetics due to financial constraints. 
 
 In conclusion, type 2 diabetics patients need not always obese. 
Majority (52%) belongs to normal weight and significant number (18%) 
of patients even lean in our study. Thus, lean body type 2 DM patients 
appear to be a distinct variety and a great deal of emphasis is to be 
given on its clinical profile and natural history. 
 
  
 
 
 
 
 
 
COMPARATIVE ANALYSIS 
  
COMPARATIVE ANALYSIS  
 
 
 Our study includes 100 patients with type 2 diabetes. Among 
them normal weight (52%), obese patients (30%) and lean type 2 
diabetics (18%). But the study  
 
i) Conducted at Manipal by Prabhu Mukhyaprana in Sudha 
Vidyasagar included 500 type 2 diabetic patients between July 
2000 and January 2001. 
 
ii) The study conducted by Gohul Dr. Desai VK at M.P. Shah 
Medical College, Jamnagar, published in JAPI, Dec 2003 
included 75 patients with Type 2 Diabetes Mellitus. 
 
1. Percentage of Lean Body Weight Type 2 DM Population 
 In our study, Lean Type 2 DM observed were 18%, as compare 
to 52% of normal and 30% of obese patients. 
 Study conducted (by Mukhyaprana et al) were 7.4% 
and majority (65%) were normal weight. 
 Incidence of lean body weight – Diabetes in various 
Indian studies ranges from 1.6% as in Ramachandran 
et al. study to as high as 28% as in Tripathi et al.  
 Mohan et al reported an incidence of 3.5%.  
  
2. Age Group 
 In our study there is no statistically significant relationship 
between age and BMI observed. 33.6% of lean type 2 DM, were 
between 51-60 years of age.   
i) But study conducted by Prabhu et al, mean age of onset of 
diabetes in lean were 60.34 + 13.5 years. 
ii) In Gohel DR. et al study it was between 30-40 years. 
 
3. Sex 
 In our study, lean type 2 Diabetes patients were slightly higher in 
female sex (22.7%) with sex ratio of 0.8 : 1 – male : female values 
were statistically significant with 'p' value 0.0364. 
i) Study conducted by Prabhu Mukhyaprana M et al observed 
most lean type 2 DM were males (65% of total lean) type 2 
DM which was statistically not significant. 
ii) Study conducted by Gohel Dr., Desai VK et al observed male 
: females ratio - 3 : 2 in lean diabetics. 
 
4. Family History 
 Positive family history was present only in 4.8% of patients with 
lean body weight type 2 DM as compare to 61.9% in normal weight 
and 33.3% of obese patients with type 2 DM which were statistically 
significant with 'p' 0.0399. 
  
i) Study conducted by Prabhu Mukhyaprana et al observed 
positive family history in 45% of lean and 62.6% in normal 
body weight diabetics, results were similar to studies by – 
Banerji et al and Kannan et al studies. 
ii) Study conducted by Gohel DR et al observed low incidence 
of positive family history (20%) in lean as compared to 40% 
in normal and 44% in obese patients. 
 
5. BMI and WHR – Are they related? 
 In our study 13% of lean diabetes had abnormal Waist Hip Ratio 
as compared to 30.4% in normal and 56.5% in obese patients. 
 
 Waist Hip Ratio had a statistically significant ('p' – 0.0379) 
relationship with BMI. 
 
 Previous study conducted at Manipal observed lean diabetics 
(48%) had abnormal Waist Hip Ratio, stating that significant number of 
lean diabetics (48%) had abnormal Waist Hip Ratio. This Waist Hip 
Ratio may thus be a more sensitive indicator of obesity in Indians. 
 
6. Skin fold thickness and Body Mass Index 
 Statistically significant relationship exists between SF Thickness 
and BMI. 
  
 That is As BMI increases, mean SF thickness also increases. 
 
7. Glycemic Status 
 In our study, Lean persons have higher fasting blood sugar (270 
+ 105.9) levels than obese patients with Type 2 Diabetes, which was 
statistically significant (p = 0.0425) as compare to normal obese 
patients with Type 2 Diabetes. 
i) Results were similar to studies done by Kannan et al and 
Italian Study by Pointoroly et al. This has been explained 
based on low – beta cell reserve in these patients. 
ii) Similar results were also observed in study conducted by 
Prabhu Mukyaprana et al. Fasting blood sugar was 
177.08+105.1. 
iii) Postprandial blood sugar value in Lean type 2 DM patients 
were 305.6 + 121.7 higher, even though statistically not 
significant. 
 
8. Lipid Profile 
 Analysis of lipid profile in our study showed interesting results. 
 
 Type 2 lean diabetics, had lower incidence of dyslipidemia 
as compared to all other groups. Even though only HDL 
relationship with BMI were statistically significant. 
  
 In our study HDL values were slightly higher in lean 
diabetics i.e. (41.0 + 2.0) as compare to (38 + 4) in normal 
and (33 + 6) in obese patients, which was statistically 
significant (p – 0.0037). 
 Also free cholesterol value in lean diabetics were (180 + 
53) as compared to (215.9 + 61.9) and (230.7 + 55.7) in 
obese patients. 
 Triglycerides value in lean diabetics (145 + 20) as 
compared to (158.8 + 41.3) in normal and (164.6 + 24.9) 
in obese diabetics. 
 
Previous studies by Banerji et al and Das et al had showed 
slight increase in TGL and HDL in lean diabetics. 
 
Japanese study by  Ikeda et al showed no major differences in 
lipid profile in lean diabetics, irrespective of glycemic status. 
 
9. Complications 
 In our study, increased incidence of microvascular 
complications like neuropathy, retinopathy observed which is 
statistically significant. 
 
  
 77.8% of lean patients, had neuropathy as a presenting 
complaint as compared to 46.2% in normal and 26.7% in obese 
patients with a 'p' value of 0.0399 (significant). 
 
 Retinopathy also increased in lean type 2 Diabetics with 66.7% 
in lean, 26.9% in normal and 33.3% in obese patients with a ‘p’ value 
of 0.0436 (Significant). 
 
 In our study nephropathy observed only in 44.4% of lean 
patients as compared to 50% in normal and 53.3% of obese type 2 
diabetics, which is not statistically significant. 
 
Study conducted at Manipal showed microvascular 
complications were similar in all the 3 groups.  
 
 Macrovascular complications like HT, IHD were less in lean 
diabetics as compared to other groups. 
  
 In our study, the incidence of hypertension was 22.2% in lean as 
compared to 23.1 in Normal and 46.7 % in Obese. Incidence of IHD in 
lean was 0 % in comparison with 23.1% in normal and 20% in Obese. 
 
  
Incidence of hypertension was 8.9% and IHD 10.2% IN Nigan et 
al study. 
 
In Manipal study the incidence of IHD only 2.7% among lean 
and HT only 16.7% of lean diabetics. 
  
Infections 
 In our study 66.7% of lean patients with type 2 diabetes 
presented with infections as compared to 23.1% in normal and 33.3% 
in obese patients. 
 
 Values were specifically significant also. ( ‘p’ value = 0.0314) 
 
 Mohan et al reported increased prevalence of retinopathy, 
neuropathy and nephropathy in lean diabetics. 
 
 Peripheral neuropathy was the commonest presenting 
complication among lean diabetics in a study by Das et al. 
 
 Peripheral neuropathy and infections were the commonest 
presenting clinical features in lean diabetics observed in study 
conducted by Gohel et al. 
 
 
  
 
 
 
 
 
SUMMARY 
  
SUMMARY 
 
 Total Number of patients studied – 100. Out of 100 
patients, 56 were male and remaining 44 were female. 
 Number of lean type 2 DM Patients were 18. Among them 
44% were Male and 56% were Female. 
 Number of normal weight type 2 diabetics were 52. 
Among them  73% were male and 27% were female. 
 Number of obese type 2 diabetics patients were 30. 
Among them 33% were male and 67% were female. 
 Most of diabetics in our population (52%) have normal 
body weight. Lean Type 2 Diabetics form significant 
number (18%). 
 Low incidence of positive family history in lean type 2 
diabetics (4.8%). Increased incidence of higher fasting 
plasma glucose in lean diabetics. 
 Peripheral neuropathy (77.8%), Retinopathy (66.7%) and 
infections (66.7%) were the major presenting clinical 
complications in lean diabetics. 
 Most risk factors of atherosclerosis and CAD are less 
prevalent in lean type 2 diabetes (Normal HDL, and total 
cholesterol on lower side). 
  
 
 
 
 
 
CONCLUSION 
  
CONCLUSION 
 
a. Majority of type 2 diabetes patients in our population 
having normal weight (52%) and lean body weight 
contributes to 18%. 
 
b. Lean diabetics have more severe hyperglycemia and 
poor metabolic control. They are more prone for 
microvascular complications like neuropathy and 
retinopathy. 
 
c. Early treatment with insulin in lean type 2 diabetics is 
mandatory to achieve good glycemic control and to 
prevent future complications. 
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PROFORMA 
 
CLINICAL PROFILE OF LEAN BODY WEIGHT TYPE 2 DM PATIENTS IN 
COMPARISON WITH OBESE AND NON-OBESE TYPE 2 DM PATIENTS 
 
Date of Registration     Special study No. 
Name    Age     Single 
Address    Sex M   Married 
Religion     F   Occupation 
Sedentary  
Active  
Income 
New case  Already treated case  How long 
 
PRESENTING SYMPTOMS AT THE TIME OF DETECTION 
 
Symptoms YES NO 
Polyuria   
Nocturia   
Polydypsia   
Polyphaqia   
Tiredness   
Weight loss  
Giddiness   
Blurrinq of vision  
Skin infection  
Itching   
Vomiting   
Abdominal pain  
Constipation 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Nocturnal Diarrhoea
  
Numbness   
Pruritus vulvae  
Sexual Dysfunction
  
Balanitis   
joint / body pain  
Ulcer 
 
Previous treatment Insulin     Regular 
Tablets  
Diet     Irregular 
Alternative 
 
Previous illness M.I    Accidents 
HT     Operations 
PT     Other op 
Jaundice 
 
Family History of Diabetes  Yes/no 
Father    Brother   Sons 
Mother    Sister   Daughters 
Wife    Husband 
 
Personal History 
Fondness for sweets  Yes/no 
Smoking   Yes/no   How long 
Alcohol   Yes/no   How long 
Vegetarian  Yes/no 
Non- veg  Yes/no 
Total Calories per day 
 
Examination 
General 
        Acanthosis Nigricans 
 
 
        Skin tag 
  
 
Xanthoma  Xanthelasma 
Thyroid swelling 
     BP Lying 
Pulse      Standing 
 
Anthropometry 
Height   Weight   Ideal wt. 
In cms  kgs   over wt. 
        Under wt. 
        (Lean) 
 
BMI 
Waist     Hip   Waist / hip (WHR) 
Circumference  circumference 
        Skin fold thickness 
System  
 CVS 
 Respiratory 
 Abdomen 
 CNS 
Opthalmological  
 
INVESTIGATIONS 
Urine -    Albumin  
Sugar  
Deposits 
 
Blood sugar  Fasting  
   Post prandial 
Blood urea  
Sr. creatinine  
Lipid profile TCL 
LDL 
HDL 
VLDL  
TGL 
 
ECG 
 
 
 
 
  
 
X ray    1. chest  
(for selected patients) 2. Abdomen 
 
 
ASSESMENT 
1 Type 2 DM lean  
Normal wt  
Obese 
 
2 Family history  Present  Absent 
 
3 Metabolic  Fasting Hyperglycemia  Yes/No 
 
4 vascular  IHD    Yes/no 
PVD    Yes/no 
Cardiomyopathy  Yes/no 
Retinopathy   Yes/no 
Nephropathy   Yes/no 
Neuropathy   Yes/no 
Infections   Yes/no 
 other associated  Yes/no 
disorders  
specify  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Waist Hip Ratio and BMI
12
6
38
14
4
26
0
10
20
30
40
50
60
Lean Normal Obese
Normal Abnormal
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fasting Blood sugar and BMI
16
46
24
2 6 60
5
10
15
20
25
30
35
40
45
50
Lean Normal Obese
Normal
Abnormal
Normal Abnormal
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Family History and BMI
2
26
14
16
26
16
0
5
10
15
20
25
30
Lean Normal Obese
Yes No
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardiac and BMI
0
12
6
18
40
24
0% 20% 40% 60% 80% 100%
Lean
Normal
Obese
Present Absent
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HT Incidence and BMI
4
14
12
40
14
16
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Lean Normal Obese
Present Absent
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neuropathy and BMI
14
4
24
28
8
22
0
5
10
15
20
25
30
Lean Normal Obese
Present Absent
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retinopathy and BMI
12
6
14
38
10
20
0 5 10 15 20 25 30 35 40
Lean
Normal
Obese
Present Absent
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Renal and BMI
8
26
16
10
26
14
0
5
10
15
20
25
30
Lean Normal Obese
Present
Absent
Present Absent
8
26
16
  
 
 
 
 
 
 
 
 
 
Infections and BMI
6
40
20
12 12 10
0
5
10
15
20
25
30
35
40
Lean Normal Obese
Present
Absent
Present Absent
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